On July 29, 2022, MIT Technology Review revealed its 2021 TR50 list, which focuses on the innovative forces "born in China, led by China, and for China" based on the concept of "sustainable future". The TR50 is a list of companies that have the ability to lead the wave of technology development in China and the world in the future.
Shenzhen Shenxin Biotechnology Co., Ltd. (hereinafter referred to as "Innorna") was listed on the list with its mRNA core delivery technology and proprietary LNP technology platform. This is the second time that Innorna has been selected as one of MIT Technology Review's "50 Smart Companies". Innorna has been selected as one of the 2020 MIT Technology Review's "50 Smart Companies" for "keeping pace with the international mRNA drug development giants (Moderna/BioNTech/CureVac) in terms of R&D methods and delivery systems, and its unique IP-based next-generation lipid nanoparticle (LNP) delivery technology is at the international leading level". MIT Technology Review's "50 Smart Companies" for 2020.
The MIT TR50 is one of the most authoritative technology business lists in the world, and is considered a global trendsetter for technology innovation and a guide to the future of emerging technologies. Since its inception in 2010, the MIT TR50 has included companies such as Microsoft, Nvidia, Tesla, Huawei and other technology giants in their respective fields, as well as many smaller but high-potential up-and-comers that have come together to paint a picture of the future of technological progress for society as a whole.